Literature DB >> 22899767

Ventilatory power: a novel index that enhances prognostic assessment of patients with heart failure.

Daniel E Forman1, Marco Guazzi, Jonathan Myers, Paul Chase, Daniel Bensimhon, Lawrence P Cahalin, Mary Ann Peberdy, Euan Ashley, Erin West, Karla M Daniels, Ross Arena.   

Abstract

BACKGROUND: Minute ventilation/CO(2) production (VE/Vco(2)) slope is an index determined by cardiopulmonary exercise testing, which incorporates pertinent cardiac, pulmonary, and skeletal muscle physiology into a substantive composite assessment. The VE/Vco(2) slope has many applications, including utility as a well-validated prognostic gauge for patients with heart failure (HF). In this study, we combine VE/Vco(2) slope with systolic blood pressure, creating a novel index that we labeled ventilatory power. Ventilatory power links the combined physiology inherent in the VE/Vco(2) slope to peripheral pressure, adding an additional dimension pertinent to HF assessment. Whereas the related concept of circulatory power links peak oxygen consumption with peak systolic blood pressure as a prognostic index, we hypothesized that ventilatory power would provide greater prognostic discrimination than VE/Vco2 slope, peak oxygen consumption, and circulatory power for patients with systolic HF. METHODS AND
RESULTS: Patients with systolic HF (left ventricular ejection fraction ≤35%) underwent symptom-limited cardiopulmonary exercise testing as part of routine management and were followed for up to 4 years for major cardiac events (mortality, left ventricular assist device implantation, and heart transplantation). Eight hundred seventy-five patients with HF (left ventricular ejection fraction, 26±9%; mean age, 55±14) were studied. Cardiopulmonary exercise testing indices peak oxygen consumption, VE/Vco(2) slope, circulatory power, and ventilatory power were all predictive of cardiac events (P<0.001). Multivariate analysis demonstrated that ventilatory power was the strongest indicator of prognosis.
CONCLUSIONS: Although circulatory power and traditional cardiopulmonary exercise testing parameters can be used to predict prognosis among patients with HF, ventilatory power provides relatively greater prognostic discrimination and may constitute a relatively more useful composite tool.

Entities:  

Mesh:

Year:  2012        PMID: 22899767      PMCID: PMC7236613          DOI: 10.1161/CIRCHEARTFAILURE.112.968529

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  21 in total

Review 1.  ATS/ACCP Statement on cardiopulmonary exercise testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-01-15       Impact factor: 21.405

2.  Low systolic blood pressure at admission predicts long-term mortality in heart failure with preserved ejection fraction.

Authors:  Otilia Buiciuc; Dan Rusinaru; Franck Lévy; Marcel Peltier; Michel Slama; Laurent Leborgne; Christophe Tribouilloy
Journal:  J Card Fail       Date:  2011-09-09       Impact factor: 5.712

3.  Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).

Authors:  D P Francis; W Shamim; L C Davies; M F Piepoli; P Ponikowski; S D Anker; A J Coats
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

4.  A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure.

Authors:  Jonathan Myers; Ross Arena; Frederick Dewey; Daniel Bensimhon; Joshua Abella; Leon Hsu; Paul Chase; Marco Guazzi; Mary Ann Peberdy
Journal:  Am Heart J       Date:  2008-09-16       Impact factor: 4.749

Review 5.  2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

Review 6.  Recommendations on the use of exercise testing in clinical practice.

Authors:  P Palange; S A Ward; K-H Carlsen; R Casaburi; C G Gallagher; R Gosselink; D E O'Donnell; L Puente-Maestu; A M Schols; S Singh; B J Whipp
Journal:  Eur Respir J       Date:  2007-01       Impact factor: 16.671

Review 7.  Excess ventilation during exercise and prognosis in chronic heart failure.

Authors:  Darryl Y Sue
Journal:  Am J Respir Crit Care Med       Date:  2011-01-21       Impact factor: 21.405

8.  Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization.

Authors:  W S Colucci; J P Ribeiro; M B Rocco; R J Quigg; M A Creager; J D Marsh; D F Gauthier; L H Hartley
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

9.  Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Authors:  William T Abraham; Gregg C Fonarow; Nancy M Albert; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young
Journal:  J Am Coll Cardiol       Date:  2008-07-29       Impact factor: 24.094

Review 10.  Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure.

Authors:  Lee Ingle
Journal:  Heart Fail Rev       Date:  2007-03-28       Impact factor: 4.654

View more
  11 in total

Review 1.  Abnormalities in cardiopulmonary exercise testing ventilatory parameters in heart failure: pathophysiology and clinical usefulness.

Authors:  Marco Guazzi
Journal:  Curr Heart Fail Rep       Date:  2014-03

2.  Mild-to-moderate COVID-19 impact on the cardiorespiratory fitness in young and middle-aged populations.

Authors:  G D Back; M R Oliveira; P F Camargo; C L Goulart; C R Oliveira; K W Wende; J C Bonjorno Junior; R F Arbex; F R Caruso; R Arena; A Borghi-Silva
Journal:  Braz J Med Biol Res       Date:  2022-07-13       Impact factor: 2.904

3.  Circulatory and Ventilatory Power: Characterization in Patients with Coronary Artery Disease.

Authors:  Viviane Castello-Simões; Vinicius Minatel; Marlus Karsten; Rodrigo Polaquini Simões; Natália Maria Perseguini; Juliana Cristina Milan; Ross Arena; Laura Maria Tomazi Neves; Audrey Borghi-Silva; Aparecida Maria Catai
Journal:  Arq Bras Cardiol       Date:  2015-05-05       Impact factor: 2.000

Review 4.  Cardiopulmonary Exercise Test: Background, Applicability and Interpretation.

Authors:  Artur Haddad Herdy; Luiz Eduardo Fonteles Ritt; Ricardo Stein; Claudio Gil Soares de Araújo; Mauricio Milani; Romeu Sérgio Meneghelo; Almir Sérgio Ferraz; Carlos Hossri; Antonio Eduardo Monteiro de Almeida; Miguel Morita Fernandes-Silva; Salvador Manoel Serra
Journal:  Arq Bras Cardiol       Date:  2016-11       Impact factor: 2.000

5.  The Coupling of Peripheral Blood Pressure and Ventilatory Responses during Exercise in Young Adults with Cystic Fibrosis.

Authors:  Erik H Van Iterson; Courtney M Wheatley; Sarah E Baker; Thomas P Olson; Wayne J Morgan; Eric M Snyder
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

6.  Are heart rate dynamics in the transition from rest to submaximal exercise related to maximal cardiorespiratory responses in COPD?

Authors:  Adriana Mazzuco; Wladimir Musetti Medeiros; Aline Soares de Souza; Maria Clara Noman Alencar; José Alberto Neder; Audrey Borghi-Silva
Journal:  Braz J Phys Ther       Date:  2017-05-20       Impact factor: 3.377

7.  Circulatory power and ventilatory power over time under goal-oriented sequential combination therapy for pulmonary arterial hypertension.

Authors:  Akihiro Hirashiki; Shiro Adachi; Yoshihisa Nakano; Yoshihiro Kamimura; Shigetake Shimokata; Kyosuke Takeshita; Atsuya Shimizu; Kenji Toba; Toyoaki Murohara; Takahisa Kondo
Journal:  Pulm Circ       Date:  2017-03-21       Impact factor: 3.017

8.  Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization.

Authors:  Michele Correale; Ilenia Monaco; Armando Ferraretti; Lucia Tricarico; Monica Sicuranza; Anna Maria Gallotta; Ennio Sascia Formica; Gianfranco Acanfora; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Int J Cardiol Heart Vasc       Date:  2020-04-21

9.  Eccentric Left Ventricular Hypertrophy and Left and Right Cardiac Function in Chronic Heart Failure with or without Coexisting COPD: Impact on Exercise Performance.

Authors:  Polliana B Dos Santos; Rodrigo P Simões; Cássia da L Goulart; Meliza G Roscani; Renan S Marinho; Patrícia Faria Camargo; Renata F Arbex; Guilherme Casale; Cláudio R Oliveira; Renata G Mendes; Ross Arena; Audrey Borghi-Silva
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-03

10.  Responses to incremental exercise and the impact of the coexistence of HF and COPD on exercise capacity: a follow-up study.

Authors:  Polliana B Dos Santos; Rodrigo P Simões; Cássia L Goulart; Guilherme Peixoto Tinoco Arêas; Renan S Marinho; Patrícia F Camargo; Meliza G Roscani; Renata F Arbex; Claudio R Oliveira; Renata G Mendes; Ross Arena; Audrey Borghi-Silva
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.